325 related articles for article (PubMed ID: 38349409)
41. Prominent coagulation disorder is closely related to inflammatory response and could be as a prognostic indicator for ICU patients with COVID-19.
Liu Y; Gao W; Guo W; Guo Y; Shi M; Dong G; Ge Q; Zhu J; Lu J
J Thromb Thrombolysis; 2020 Nov; 50(4):825-832. PubMed ID: 32761495
[TBL] [Abstract][Full Text] [Related]
42. Coagulopathy in COVID-19.
Iba T; Levy JH; Levi M; Thachil J
J Thromb Haemost; 2020 Sep; 18(9):2103-2109. PubMed ID: 32558075
[TBL] [Abstract][Full Text] [Related]
43. COVID-19-associated coagulopathy.
Franchini M; Marano G; Cruciani M; Mengoli C; Pati I; Masiello F; Veropalumbo E; Pupella S; Vaglio S; Liumbruno GM
Diagnosis (Berl); 2020 Nov; 7(4):357-363. PubMed ID: 32683333
[TBL] [Abstract][Full Text] [Related]
44. Four years into the pandemic, managing COVID-19 patients with acute coagulopathy: what have we learned?
Iba T; Levy JH; Maier CL; Connors JM; Levi M
J Thromb Haemost; 2024 Jun; 22(6):1541-1549. PubMed ID: 38428590
[TBL] [Abstract][Full Text] [Related]
45. Coagulopathy and thromboembolic events a pathogenic mechanism of COVID-19 associated with mortality: An updated review.
Yousefi P; Soltani S; Siri G; Rezayat SA; Gholami A; Zafarani A; Razizadeh MH; Alborzi E; Mokhtary-Irani G; Abedi B; Karampoor S; Tabibzadeh A; Farahani A
J Clin Lab Anal; 2023 Jun; 37(11-12):e24941. PubMed ID: 37431777
[TBL] [Abstract][Full Text] [Related]
46. Role of Acute Thrombosis in Coronavirus Disease 2019.
Gibbs DV; Shreenivas SS; Hudock KM
Crit Care Clin; 2022 Jul; 38(3):491-504. PubMed ID: 35667739
[TBL] [Abstract][Full Text] [Related]
47. COVID-19 and immunothrombosis: emerging understanding and clinical management.
Shaw RJ; Bradbury C; Abrams ST; Wang G; Toh CH
Br J Haematol; 2021 Aug; 194(3):518-529. PubMed ID: 34114204
[TBL] [Abstract][Full Text] [Related]
48. Contribution value of coagulation abnormalities in COVID-19 prognosis: a bright perspective on the laboratory pattern of patients with coronavirus disease 2019.
Sayyadi M; Khosravi M; Ghaznavi-Rad E
Eur Rev Med Pharmacol Sci; 2021 Jan; 25(1):518-522. PubMed ID: 33506943
[TBL] [Abstract][Full Text] [Related]
49. Immunothrombotic Dysregulation in COVID-19 Pneumonia Is Associated With Respiratory Failure and Coagulopathy.
Nicolai L; Leunig A; Brambs S; Kaiser R; Weinberger T; Weigand M; Muenchhoff M; Hellmuth JC; Ledderose S; Schulz H; Scherer C; Rudelius M; Zoller M; Höchter D; Keppler O; Teupser D; Zwißler B; von Bergwelt-Baildon M; Kääb S; Massberg S; Pekayvaz K; Stark K
Circulation; 2020 Sep; 142(12):1176-1189. PubMed ID: 32755393
[TBL] [Abstract][Full Text] [Related]
50. Coagulopathy in patients with COVID-19: a systematic review and meta-analysis.
Zhang X; Yang X; Jiao H; Liu X
Aging (Albany NY); 2020 Nov; 12(24):24535-24551. PubMed ID: 33229625
[TBL] [Abstract][Full Text] [Related]
51. Severe SARS-CoV-2 Infection Inhibits Fibrinolysis Leading to Changes in Viscoelastic Properties of Blood Clot: A Descriptive Study of Fibrinolysis in COVID-19.
Hammer S; Häberle H; Schlensak C; Bitzer M; Malek NP; Handgretinger R; Lang P; Hörber S; Peter A; Martus P; Mirakaj V; Gawaz M; Geisler T; Althaus K; Rosenberger P; Bakchoul T
Thromb Haemost; 2021 Nov; 121(11):1417-1426. PubMed ID: 33634444
[TBL] [Abstract][Full Text] [Related]
52. Prothrombotic Phenotype in COVID-19: Focus on Platelets.
Barale C; Melchionda E; Morotti A; Russo I
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948438
[TBL] [Abstract][Full Text] [Related]
53. SARS-CoV-2 infection and thrombotic complications: a narrative review.
Moschonas IC; Tselepis AD
J Thromb Thrombolysis; 2021 Jul; 52(1):111-123. PubMed ID: 33449290
[TBL] [Abstract][Full Text] [Related]
54. [COVID-19: Coagulopathy and thrombosis].
Tazi Mezalek Z
Rev Med Interne; 2021 Feb; 42(2):93-100. PubMed ID: 33509669
[TBL] [Abstract][Full Text] [Related]
55. Hemostatic laboratory derangements in COVID-19 with a focus on platelet count.
Amgalan A; Othman M
Platelets; 2020 Aug; 31(6):740-745. PubMed ID: 32456506
[TBL] [Abstract][Full Text] [Related]
56. NETosis and Neutrophil Extracellular Traps in COVID-19: Immunothrombosis and Beyond.
Zhu Y; Chen X; Liu X
Front Immunol; 2022; 13():838011. PubMed ID: 35309344
[TBL] [Abstract][Full Text] [Related]
57. Coagulopathy in COVID-19: Manifestations and management.
Mucha SR; Dugar S; McCrae K; Joseph D; Bartholomew J; Sacha GL; Militello M
Cleve Clin J Med; 2020 Jul; 87(8):461-468. PubMed ID: 32409435
[TBL] [Abstract][Full Text] [Related]
58. Role of SARS-CoV-2 -induced cytokines and growth factors in coagulopathy and thromboembolism.
Ahmad F; Kannan M; Ansari AW
Cytokine Growth Factor Rev; 2022 Feb; 63():58-68. PubMed ID: 34750061
[TBL] [Abstract][Full Text] [Related]
59. Corona Virus Disease 2019 (COVID-19) as a System-Level Infectious Disease With Distinct Sex Disparities.
Emadi-Baygi M; Ehsanifard M; Afrashtehpour N; Norouzi M; Joz-Abbasalian Z
Front Immunol; 2021; 12():778913. PubMed ID: 34912345
[TBL] [Abstract][Full Text] [Related]
60. A Review of Pathophysiology, Clinical Features, and Management Options of COVID-19 Associated Coagulopathy.
Goswami J; MacArthur TA; Sridharan M; Pruthi RK; McBane RD; Witzig TE; Park MS
Shock; 2021 Jun; 55(6):700-716. PubMed ID: 33378321
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
